Fonar Current Ratio 2010-2025 | FONR

Fonar current ratio from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Fonar Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2025-03-31 $0.14B $0.01B 10.05
2024-12-31 $0.14B $0.01B 11.24
2024-09-30 $0.14B $0.01B 9.64
2024-06-30 $0.14B $0.02B 7.86
2024-03-31 $0.14B $0.02B 9.37
2023-12-31 $0.13B $0.01B 9.35
2023-09-30 $0.13B $0.01B 9.07
2023-06-30 $0.13B $0.02B 8.04
2023-03-31 $0.12B $0.01B 8.76
2022-12-31 $0.12B $0.01B 8.79
2022-09-30 $0.12B $0.02B 8.01
2022-06-30 $0.12B $0.02B 7.09
2022-03-31 $0.11B $0.01B 8.07
2021-12-31 $0.11B $0.01B 8.13
2021-09-30 $0.11B $0.02B 6.73
2021-06-30 $0.11B $0.02B 5.42
2021-03-31 $0.10B $0.02B 6.06
2020-12-31 $0.10B $0.02B 6.00
2020-09-30 $0.10B $0.02B 5.32
2020-06-30 $0.10B $0.02B 5.14
2020-03-31 $0.09B $0.02B 6.14
2019-12-31 $0.09B $0.02B 6.03
2019-09-30 $0.09B $0.01B 6.25
2019-06-30 $0.09B $0.01B 6.04
2019-03-31 $0.08B $0.01B 6.99
2018-12-31 $0.07B $0.01B 6.33
2018-09-30 $0.07B $0.01B 5.99
2018-06-30 $0.07B $0.02B 4.60
2018-03-31 $0.06B $0.01B 4.96
2017-12-31 $0.06B $0.01B 4.43
2017-09-30 $0.06B $0.01B 4.05
2017-06-30 $0.05B $0.01B 3.75
2017-03-31 $0.05B $0.01B 3.52
2016-12-31 $0.05B $0.02B 2.81
2016-09-30 $0.05B $0.02B 2.57
2016-06-30 $0.05B $0.02B 2.21
2016-03-31 $0.05B $0.02B 2.74
2015-12-31 $0.05B $0.02B 2.57
2015-09-30 $0.05B $0.02B 2.38
2015-06-30 $0.04B $0.02B 2.32
2015-03-31 $0.04B $0.02B 2.13
2014-12-31 $0.05B $0.02B 2.24
2014-09-30 $0.05B $0.02B 2.07
2014-06-30 $0.04B $0.02B 2.05
2014-03-31 $0.04B $0.02B 1.95
2013-12-31 $0.04B $0.02B 1.88
2013-09-30 $0.04B $0.02B 1.84
2013-06-30 $0.04B $0.02B 1.79
2013-03-31 $0.04B $0.02B 1.63
2012-12-31 $0.03B $0.02B 1.38
2012-09-30 $0.03B $0.02B 1.30
2012-06-30 $0.03B $0.02B 1.23
2012-03-31 $0.03B $0.02B 1.20
2011-12-31 $0.03B $0.02B 1.15
2011-09-30 $0.02B $0.02B 1.06
2011-06-30 $0.02B $0.02B 0.98
2011-03-31 $0.02B $0.02B 0.70
2010-12-31 $0.02B $0.03B 0.61
2010-09-30 $0.02B $0.03B 0.61
2010-06-30 $0.02B $0.03B 0.59
2010-03-31 $0.02B $0.03B 0.59
2009-12-31 $0.02B $0.03B 0.59
2009-09-30 $0.02B $0.03B 0.64
2009-06-30 $0.02B $0.03B 0.63
2009-03-31 $0.02B $0.03B 0.60
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.096B $0.103B
FONAR Corporation is a developer and manufacturer of MRI scanners. The Company has introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's stellar product is the UPRIGHT MRI, also known as the Stand-Up MRI, the whole-body MRI that performs Position imaging and scans patients in numerous weight-bearing positions like standing, sitting, in flexion and extension, as well as the conventional lie-down position. The Company's subsidiary, Health Management Corporation of America, is a physician practice management company providing management services to medical providers. FONAR Corporation is based in Melville, New York.
Stock Name Country Market Cap PE Ratio
Boston Scientific (BSX) United States $152.324B 38.13
Stryker (SYK) United States $149.641B 31.29
EssilorLuxottica (ESLOY) France $137.721B 0.00
Medtronic (MDT) Ireland $114.146B 16.18
Lonza Group Ag (LZAGY) Switzerland $51.237B 0.00
Haleon (HLN) United Kingdom $45.147B 25.77
ResMed (RMD) United States $37.534B 28.19
GE HealthCare Technologies (GEHC) United States $34.575B 16.42
Agilent Technologies (A) United States $34.457B 22.46
Terumo (TRUMY) Japan $25.051B 32.54
Koninklijke Philips (PHG) Netherlands $23.235B 16.30
Insulet (PODD) United States $20.934B 82.17
Zimmer Biomet Holdings (ZBH) United States $18.835B 12.10
Baxter (BAX) United States $15.298B 11.42
Smith & Nephew SNATS (SNN) United Kingdom $13.441B 0.00
Demant (WILYY) Denmark $8.971B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.887B 23.97
Lantheus Holdings (LNTH) United States $5.776B 14.57
Prestige Consumer Healthcare (PBH) United States $3.897B 17.41
Perrigo (PRGO) Ireland $3.742B 9.48
Haemonetics (HAE) United States $3.724B 16.96
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.454B 28.70
ICU Medical (ICUI) United States $3.341B 24.63
QuidelOrtho (QDEL) United States $2.135B 14.68
LeMaitre Vascular (LMAT) United States $1.910B 42.70
AtriCure (ATRC) United States $1.580B 0.00
Acuren (TIC) United States $1.397B 0.00
Phibro Animal Health (PAHC) United States $1.272B 16.26
Green Thumb Industries (GTBIF) United States $1.249B 28.09
AdaptHealth (AHCO) United States $1.247B 12.66
Neogen (NEOG) United States $1.194B 15.28
BioLife Solutions (BLFS) United States $1.068B 0.00
InMode (INMD) Israel $0.963B 9.70
Kestra Medical Technologies (KMTS) United States $0.791B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.703B 0.00
Tilray Brands (TLRY) Canada $0.679B 0.00
Curaleaf Holdings (CURLF) Canada $0.670B 0.00
Owens & Minor (OMI) United States $0.667B 5.53
Evolus (EOLS) United States $0.623B 0.00
CeriBell (CBLL) United States $0.596B 0.00
Capricor Therapeutics (CAPR) United States $0.522B 0.00
Valneva SE (VALN) France $0.502B 0.00
Surmodics (SRDX) United States $0.441B 0.00
SNDL (SNDL) Canada $0.373B 0.00
VAREX IMAGING (VREX) United States $0.347B 12.77
Sanuwave Health (SNWV) United States $0.308B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.304B 0.00
Quanterix (QTRX) United States $0.295B 0.00
Cresco Labs (CRLBF) United States $0.291B 0.00
Cerus (CERS) United States $0.285B 0.00
Viemed Healthcare (VMD) United States $0.276B 23.27
Sanara MedTech (SMTI) United States $0.269B 0.00
ZimVie (ZIMV) United States $0.264B 12.01
Brainsway (BWAY) Israel $0.246B 65.00
Canopy Growth (CGC) Canada $0.232B 0.00
OraSure Technologies (OSUR) United States $0.227B 0.00
Biote (BTMD) United States $0.225B 6.34
Verano Holdings (VRNOF) United States $0.210B 0.00
Omeros (OMER) United States $0.198B 0.00
Organigram Global (OGI) Canada $0.193B 0.00
High Tide (HITI) Canada $0.190B 0.00
TriSalus Life Sciences (TLSI) United States $0.190B 0.00
Utah Medical Products (UTMD) United States $0.186B 15.15
Vireo Growth (VREOF) United States $0.150B 0.00
Exagen (XGN) United States $0.145B 0.00
FitLife Brands (FTLF) United States $0.126B 15.53
TerrAscend (TSNDF) Canada $0.104B 0.00
MacroGenics (MGNX) United States $0.100B 0.00
Jin Medical (ZJYL) China $0.093B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.089B 0.00
Apyx Medical (APYX) United States $0.086B 0.00
Quipt Home Medical (QIPT) United States $0.082B 0.00
Veru (VERU) United States $0.081B 0.00
Jushi Holdings (JUSHF) United States $0.072B 0.00
Zynex (ZYXI) United States $0.072B 0.00
InterCure (INCR) Israel $0.072B 0.00
Agape ATP (ATPC) $0.071B 0.00
Cytosorbents (CTSO) United States $0.070B 0.00
ImmuCell (ICCC) United States $0.061B 0.00
Rockwell Medical (RMTI) United States $0.041B 0.00
Nephros (NEPH) United States $0.040B 53.29
Modular Medical (MODD) United States $0.039B 0.00
United-Guardian (UG) United States $0.037B 12.82
Safety Shot (SHOT) United States $0.033B 0.00
Allurion Technologies (ALUR) United States $0.021B 0.00
INLIF (INLF) $0.016B 0.00
IM Cannabis (IMCC) Canada $0.014B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Senestech (SNES) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00